Meridian Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Meridian Wealth Management's IBB Position: Q3 2026 in Review
Meridian Wealth Management reduced its iShares Biotechnology ETF (IBB) stake by 9.7% in Q3 2026, selling an estimated $76.8K and leaving 3,574 shares worth $752K. The position accounts for 0.02% of the portfolio, ranked #447.
Meridian Wealth Management first reported a position in IBB in Q2 2019 and has held it in 24 quarters since. The position peaked at $1.24M in Q3 2023. 1,031 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- Meridian Wealth Management held 3,574 shares of iShares Biotechnology ETF worth $752K as of Q3 2026.
- Meridian Wealth Management sold 383 iShares Biotechnology ETF shares in Q3 2026, an estimated $76.8K.
- iShares Biotechnology ETF made up 0.02% of Meridian Wealth Management's portfolio in Q3 2026, its #447 holding.
- Meridian Wealth Management first reported a position in iShares Biotechnology ETF in Q2 2019 and has held it in 24 quarters since.
- Meridian Wealth Management's iShares Biotechnology ETF position peaked at $1.24M in Q3 2023.
- 1,031 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on Meridian Wealth Management's 13F filing for Q3 2026, filed 5 Nov 2026.